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Abstract
The article considers the questions of a necessity of widening the list of obligatory preoperative examinations of patients 
with obesity for the choice of adequate operation volume, especially for simultaneous debulking of a greater omentum. The aim of 
research is an estimation of possibility of using an insulin resistance index (НОМА – IR) as a necessity criterion of simultaneous 
debulking of a greater omentum at operative interventions in patients with obesity. 
There were examined 60 persons from the surgical stationary, divided in 2 groups. 1 group included 20 patients with the 
normal body mass, 2 – 40 patients with different degrees of obesity. Insulin resistance was revealed on the base of glucose and insulin 
estimation, HOMA-IR index calculation. 
It was revealed, that glucose level in all patients doesn’t reliably exceeds the upper threshold of norm, insulin rates don’t dif-
fer from the control ones, even in patients with obesity, and rise in 20 % of patients only at 3 degree of obesity. It creates an illusion 
about the normal state of carbohydrate metabolism in these patients, whereas insulin resistance index estimation allows to reveal a 
pre-clinic stage of these disorders and to make a timely decision as to a possibility and necessity of simultaneous palliative operation 
as an omentectomy that doesn’t complicate a course of operation and postoperational period, but allows to decrease an expressiveness 
of carbohydrate metabolism disorders at obesity. 
The standard preoperative estimation of glucose level in blood doesn’t allow to diagnose an insulin resistance state, that is 
patients of the high risk group of metabolic syndrome development (especially the ones with obesity) need the additional insulin 
estimation and insulin resistance index calculation in preoperational period. 
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1. Introduction
Among surgical problems the special place is occupied by the ones of simultaneous sur-
gery [1]. It is caused by different factors. First of all it is connected with anesthesiology, reanima-
tology and surgery achievements. Innovative technologies allow to reduce an operation time essen-
tially, to widen its volume, to realize several operations at one intervention [2]. No less important 
direction is a palliative surgery that doesn’t completely solve all patients’ problems but allows 
to increase their life quality [3]. These operations give a possibility to decelerate or stabilize the 
pathological processes development, to lighten a patient’s state and/or prolong its life. It is a base for 
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searching objective predictors of pathological processes development that allow to make a timely 
decision as to a necessity of simultaneous operative intervention for preventing a hidden or latent 
disease progression, lightening of a patient’s state. 
It is well-known, that the ones of most serious comorbidity risk factors are obesity and 
metabolic syndrome [4]. This combination conditions oncogenesis [5], development of such heavy 
diseases as diabetes mellitus type 2, stroke, myocardium infarction, fatty hepatosis, associated 
with osteoarthritis, night apnea, respiratory function disorders and many other diseases, less heavy 
but also causing invalidism [6]. Hypertonic disease development is also connected with obesity and 
metabolic syndrome [7].
The accepted criterion of carbohydrate metabolism disorder in literature is an insulin resis-
tance state (IR), diagnosed using НОМА – IR index [8]. Since IR develops at first in endothelial 
then in muscular then in hepatic and fatty tissue, it is clear that this index reflects the process not in 
the early stage of its development but testifies to the presence of hidden diabetes type 2 [9]. 
Today IR role in metabolic syndrome and its vascular complications development as an in-
fraction, stroke, in initiation of chronic inflammation in fatty tissue, production of inflammatory 
cytokines and tumor necrosis factor is already not doubted. There were also carried out many studies, 
testifying to the favorable influence of bariatric operations on an insulin resistance state [10]. The ef-
fect of bariatric operations is based on the increase of fatty tissue amount that is agreed with the data 
of 27 studies, indicating the favorable effect of physical exercises on an insulin resistance index [11].
It was proved, that the maximal toxic effect, activator of endothelial dysfunction initia-
tion [12], insulin resistance and diabetes [13], atherosclerotic processes [14] and oncogenesis is a 
visceral fatty tissue [15]. And omentectomy, due to cytoreduction of metabolically aggressive fatty 
tissue, favors the decrease of metabolic disorders and stabilization of the process, especially insulin 
resistance [16]. Simultaneous debulking of visceral fat (omentectomy) at the main surgical oper-
ation is a technically easy stage that doesn’t load a patient with additional financial costs, doesn’t 
increase a time of staying in a hospital and doesn’t burden the course of postoperative period [17]. 
But if the necessity of simultaneous omentectomy at bariatric operations is doubted [18], because a 
bariatric operation normalizes a carbohydrate metabolism state itself [19], simultaneous debulking 
of a greater omentum [20], at widespread and not complicated abdominal operations is grounded 
and logic because of its palliative effect at subclinical diabetes and carbohydrate metabolism dis-
orders. Nevertheless, necessity criteria of simultaneous palliative debulking of visceral fat are not 
determined in practical surgery till today; the obligatory estimation of insulin resistance at pre- 
operational stage is not introduced. 
2. Aim of research
To estimate a possibility of using insulin resistance index (НОМА – IR) as a necessity criteri-
on of simultaneous debulking of a greater omentum at operative interventions in patients with obesity. 
3. Material and methods of research
60 patients of the surgical hospital were examined. Besides general clinical examinations, 
they underwent a glucose and insulin level estimation, НОМА – IR, index, height-weight index 
(Ketele index) calculation, abdomen measuring by a centimeter ribbon. Ketele index (or body mass 
index, BMI) is calculated as a ratio of a weight in kilograms to a height square in meters: =kg/m². 
Glucose and insulin were estimated in blood plasma after 8–14 hour night fasting. НОМА – IR index 
was calculated by the formula: glucose fasting (mmol\l) multiplied by insulin fasting (mc Un/ml) 
and divided by 22,5. Diabetes mellitus and terminal states were referred to exclusion criteria. The 
rest of diseases were not a selective criterion for exclusion. 
All patients were divided in two groups, depending on Ketele index. The first group included 
patients, which body mass was within normative values (didn’t exceed 24,9). The second one included 
40 patients with different degrees of obesity (Ketele index exceeded 30,0). In their turn, patients of the 
second group were dived in subgroups: 2А – patients with 1 degree of obesity, 2В – with 2 degree of 
obesity and 2С – with 3 degree of obesity.
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Groups were comparable by age, type and volume of operations. The gender analysis demon-
strated women prevalence in both groups. It is possibly connected with a social problem of female 
population prevalence in the country. 
4. Results of research
The data about carbohydrate metabolism state of patients of the surgical hospital, admitted 
because of different planned surgical pathologies are presented in the Table 1. 
Table 1
Data about carbohydrate metabolism state of patients of the surgical hospital 
Insulin, mcIU/ml Glucose, mmol/l HOMA – IR index
Group 1
 n=20
8,48±0,74 4,62±0,17 1,72± 0,16
Group 2
 n=40
25,31±4,31 4,80±0,14 5,54±0,99
Group 2А
 n=6
12,69±0,96 4,71±0,33 2,65±0,27
Group 2В
 n=10
16,14±1,61 4,83±0,25 3,55±0,50
Group 2С
 n=24
32,28±6,82 4,82±0,20 7,10±1,57
It turned out that patients of the first group with the normal body mass had mean blood glu-
cose level, insulin level, and their own indices within physiological norm. Individual parameters 
of HOMA – IR index of each examined person from this group did not also exceed physiological 
fluctuations, and the mean index was lower than the upper admissible threshold by 36,3 %.
As a whole, only in 5 patients of 40 ones with obesity the level of glucose a bit (unreliably) 
exceeded the upper admissible threshold. The detail analysis, depending on the obesity degree, 
demonstrated that the unessential increase of glucose level was observed in 1 patient with 1 degree 
of obesity, in 1 with 2 degree of obesity and in 3 patients with 3 degree of obesity. All these patients, 
even ones with 3 degree of obesity, in postoperative period, after pre- and postoperative dietary 
limitation had glucose indices, correspondent to the normative values. 
An insulin level in patients with the normal body mass was by 38,3 % lower than the norma-
tive values median (2,60–24,9). And at obesity an insulin level is 3,0 times more than the indices 
of 1 group (Р<0,001), but at that оnly by 1,6 % exceeded the upper norm limit. The detail analysis 
revealed certain features at obesity of different degrees. It turned out, that if at 1 and 2 degree of 
obesity there were not estimated changes in the mean values of insulin level and glucose level in 
blood, at 3 degree of obesity the insulin index increased in 3,8 times (Р<0,001). But in this group 
also the changes of insulin index were observed only in 20 % patients (although they were rather 
significant, the mean insulin index reached 70,15 mcIU/ml that 2,8 exceeds the index of upper norm 
threshold and 8,3 times the index of patients of the first group without obesity). In the rest 80 % of 
patients with 3 degree of obesity neither hyperglycemia, nor hyperinsulinemia were not observed. 
At obesity IR index 3,2 times exceeded the ones of patients of 1 group and was in average 5,54. 
At that, if at 1 degree of obesity the mean HOMA indices did not reliably exceed the upper norm limit, 
although they were 1,5 times more (Р<0,01), than the ones of 1 group, at 2 degree of obesity IR index 
2,1 times exceeded the control ones (Р<0,005), and at 3 degree of obesity – 4,1 times (Р≤0,001). 
5. Discussion of research results
This study demonstrated that in patients with the normal body mass (diabetes was an exclu-
sion criterion) the levels of insulin and glucose corresponded to the mean physiological parameters. 
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The insulin resistance state was not registered in none case. HOMA – IR index in none case ex-
ceeded the normative threshold – 2,7.
The situation cardinally changes in patients with obesity but it was revealed only after not 
only glucose but also insulin level estimation and insulin resistance level calculation. It is necessary 
to pay attention to the fact that the mean glucose index corresponded to the physiological values 
median and absolutely could not direct a doctor on guessing IR presence in these patients. So, the 
choice of anesthetic support, observation place in postoperative period (intensive care department 
or recovery room in surgical department), operation method was carried out without taking into 
account such important factor of early and late complications as insulin resistance. Neither clinical 
data that testify to the insulin resistance state, nor biochemical disorders in the glucose index, con-
sidered for today as the main factor that reflect the carbohydrate metabolism state, practically were 
not observed. It naturally influenced clinical decisions. 
The received data testify to the ones of other scientists about late changes of blood glucose 
level at carbohydrate metabolism disorders. That is just why it is recommended throughout the 
world not to limit oneself to determination of a blood hyperglycemia level but to estimate IR and 
insulin levels. 
But it is also not possible to rely on an insulin index. Its mean value is within the normative 
values. And the individual analysis revealed disorders only in 20 % of patients. That is there were 
not registered any biochemically significant, reliable changes of insulin level. 
At the surface approach there are all grounds for not taking these indices into account and 
even not guessing IR presence in these patients, and taking into account only diabetes mellitus at 
making clinical decisions. 
But taking into account that fact that IR already develops and progresses at the normal 
insulin and glucose indices, that it is reflected (already at the expressed stage at insulin resistance 
of endothelial, muscular tissue, at the stage of insulin resistance development in hepatic and fatty 
tissue) by not so much the absolute values of glucose and insulin as the disorder of their ratio, and 
hyperglycemia and hyperinsulinemia develop not only the disturbance of compensating possibili-
ties of an organism, the study of HOMA – IR index was realized.
It turned out that in patients with the normal body mass HOMA – IR index corresponded to 
the normative values, so testified to the absence of hepatic and fatty tissue IR. 
This situation cardinally changes at obesity. It is necessary to pay attention to the fact that 
if the glucose level in these patients unreliably exceeded the upper norm limit in 12,5 % of cases, 
and this increase was extremely unessential (that doesn’t influence decision making in practical 
work), the increase of HOMA index, testifying to insulin resistance was observed in 92,5 % of 
patients. That is at obesity that creates a risk of postoperative thromboembolism, acute coronary 
failure syndrome, long cumulation of muscle relaxants in fatty tissue and other mortal complica-
tions development, insulin resistance that can cause a series of postoperative complications itself, 
is not diagnosed. 
Thus, the received data one more time prove that at the assessment of the state of a patient 
with obesity, one must not orient only at the absolute values of glucose and/or insulin. Only 
estimation of their ratio allows to diagnose or to exclude insulin resistance. But to decrease a 
financial load at the examination in preoperative periodforn patients with the normal body mass 
and absence of other metabolic syndrome criteria, one may abstain of the deep study of carbo-
hydrate metabolism state. 
Certainly it would be desirable to extrapolate this study on patients of other surgical di-
rections (gynecological, traumatological, urological), but these recommendations are especially 
important in abdominal surgery, because IR revelation at preoperative stage can help to choose a 
correct and compliant decision about an operation volume. In particular, simultaneous omentec-
tomy that helps to stabilize or decrease carbohydrate dysfunction manifestations at the expanse 
of cytoreduction of metabolically aggressive visceral fatty tissue may be offered. Debulking of 
a greater omentum must be considered in this case as a palliative intervention that doesn’t cure a 
patient but decreases a degree of pathological carbohydrate disorders and delays the development 
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of clinical manifestations. The timely IR diagnostics will help to start a conservative therapy for 
diabetes development prophylaxis in proper time. 
6. Conclusions
1. The standard preoperative estimation of a blood glucose level doesn’t reflect carbohydrate 
disorders and doesn’t allow to diagnose an insulin resistance state. 
2. Patients with obesity, who form the high risk group as to the development of postoperative 
lethal complications, must underwent an estimation of not only blood glucose but also insulin with 
an insulin resistance level calculation in preoperative period. 
3. НОМА – IR index is a laboratory criterion of insulin resistance presence and may by a 
necessity criterion of simultaneous debulking of a greater omentum at operative intervention in 
patients with obesity. 
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